Delivery Order SPE2DE21D7009-SPE2D625F3HMW

Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, received a $43.7K fixed-price delivery order with economic price adjustment for pain management medical devices, awarded September 9, 2025, with completion targeted for September 19, 2025. The award was issued by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense, with performance to occur at the contractor's Valencia, California facility. This delivery order carries no set-aside designation and represents a task order issued under the contractor's larger indefinite delivery vehicle with the Defense Logistics Agency Troop Support Medical branch, valued at approximately $83.1M through August 2026.

The delivery order supports the federal government's provision of non-opioid pain management solutions to military treatment facilities and Department of Veterans Affairs medical centers. Boston Scientific Neuromodulation Corp specializes in advanced neuromodulation therapies, including spinal cord stimulation systems, implantable pain pumps, and radiofrequency ablation devices, along with associated accessories and technical support. The company's core mission focuses on delivering sophisticated pain management technologies to service members and veterans managing chronic pain from traumatic injuries, positioning it as a critical supplier within the federal healthcare system's broader effort to reduce opioid dependence while maintaining effective pain control capabilities.